Medtronic Expands US Robotic Surgery Footprint With New FDA General Surgery Approval
The FDA cleared Medtronic's Hugo robotic-assisted surgery system for general surgery, expanding access to 3.5 million annual U.S. cases.
Last updated: 2026-11-19 08:02:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Medtronic plc (MDT) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NYSE. The stock is currently priced at $100.71, with a market capitalization of $130.88B and a P/E ratio of 25.02. Over the past 52 weeks, its price has ranged from $73.31 to $106.33. This page covers its latest market performance, valuation, price trends and company information.
$130.88B | |
$100.86 | |
$102.74 | |
$99.63 | |
$102.32 | |
4.80M | |
16.70M | |
25.02 | |
$106.33 | |
$73.31 | |
2.79% | |
2026-07-31 |
Medtronic plc (MDT) last closed at $100.71 as of 2026-11-19 00:59:00, down 1.56% ($1.60) from the previous close of $102.32.
During the latest regular trading session, MDT traded between $99.63 and $102.74, with a volume of 4.80M shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, Medtronic plc (MDT) moved from $101.59 to $100.71, representing a decline of 0.87% ($0.88).
The stock traded between $99.59 and $104.49 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 5.69 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 83.0%
MDT is currently trading at $100.71, placing it 83.0% of the way from its 52-week low of $73.31 to its 52-week high of $106.33. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 95,000 |
| CEO | Geoffrey Straub Martha |
| Founded | 1949 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Medtronic plc.
Dividend | |
|---|---|
| Ex-Dividend Date | Sep 25, 2026 |
| Payment Date | Oct 16, 2026 |
| Dividend Per Share | $0.72 |
Latest news related to Medtronic plc and MDT stock.
The FDA cleared Medtronic's Hugo robotic-assisted surgery system for general surgery, expanding access to 3.5 million annual U.S. cases.
The global nerve repair and regeneration market is projected to grow from USD 10.65 billion in 2025 to USD 20.97 billion by 2031, expanding at an 11.96% CAGR. Growth is driven by rising nerve injuries, advances in neurostimulation technologies, and biomaterial innovations. Neurostimulation devices currently dominate with 58.74% market share, while biomaterials are the fastest-growing segment at 14.01% CAGR. High implant costs and cybersecurity risks remain challenges, with Asia-Pacific expected to record the fastest regional growth.
Analysts upgraded UNFI, ZBH, NUE, MDT and PRAX, raising price targets and ratings to Buy or Overweight.
Piper Sandler analyst Matt O'Brien upgrades Medtronic (NYSE:MDT) from Neutral to Overweight and raises the price target from $85 to $120.
Eligible investors can buy real shares of Medtronic plc (MDT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MDT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between MDT shares and USD.
MDT Shares to USD
1.00 MDT shares = 100.709 USD
Calculations are estimates based on the latest available price and are for reference only.